Marketing, FDA communication, tobacco perceptions and use in addiction treatment

描述（由申请人提供）：2009年《烟草控制法案》责成FDA监管烟草产品，以服务于公众健康。FDA确定了关键的研究重点，包括：了解烟草制品的多样性，了解烟草制品的沟通，以及了解烟草制品的营销。拓宽了烟草控制的传统重点，FDA在其56项研究重点中有11项提到了“弱势群体”。每年有400多万人接受某种形式的成瘾治疗。在这一脆弱、被剥夺权利和被污名化的人群中，许多人在我们的公共卫生部门接受卫生服务，吸烟率很高（67-75%），并且对先前的烟草控制努力不让步。由于这一人群极有可能吸烟，他们对烟草营销的接触程度很高，并有可能尝试、使用和采用一些新出现的和潜在改良的风险烟草制品。作为对PAR-12-267的回应，目前的申请将招募25个成瘾治疗项目的全国分层随机样本，其中患者将被招募到FDA研究烟草。患者将在每年三次横断面访谈中招募（每波N= 1000），并使用基于网络的计算机辅助策略，就传统和新兴烟草制品的使用、FDA沟通和烟草营销的暴露、与一系列烟草制品相关的风险认知以及烟草使用行为进行访谈。应用程序使用的混合措施标准,适应和新措施来测试假设使用任何烟草制品居高不下的随着时间的推移,使用修改后的烟草产品增加风险的人口随着时间的推移,接触食品及药物管理局通信和烟草营销是不同与烟草风险认知水平有关,和水平的风险知觉年代不同与努力减少或退出烟草使用在这个人口。由于这一人群是吸烟者集中的地方，这也是FDA优先事项中确定的信息最需要的地方，但可获得的信息最少。本研究的短期目标是了解烟草制品的使用、营销、信息传递和与这些产品相关的认知，以及它们与成瘾治疗人群中烟草使用行为的关系。长期目标是支持监管活动，以减少这一弱势群体的烟草使用和烟草风险。

DESCRIPTION (provided by applicant): The 2009 Tobacco Control Act charged the FDA with regulating tobacco products in the service of public health. The FDA identified key research priorities, including: understanding the diversity of tobacco products, understanding communications about tobacco products, and understanding tobacco product marketing. Broadening the traditional focus of tobacco control, the FDA calls out "vulnerable populations" in 11 of its 56 research priorities. Over 4 million persons receive some type of addiction treatment annually. In this vulnerable, disenfranchised and stigmatized population, where many receive health services in our public health sector, smoking rates are high (67-75%) and unyielding to prior tobacco control efforts. Because persons in this population are highly likely to smoke, they have high exposure to tobacco marketing and are likely to try, use, and adopt some emerging and potentially modified risk tobacco products. In response to PAR-12-267, the current application will recruit a national stratified random sample of 25 addiction treatment programs, where patients will be recruited to FDA research on tobacco. Patients will be recruited in three annual cross-sectional interview waves (N=1,000 per wave) and, using web-based computer assisted strategies, will be interviewed concerning use of traditional and emerging tobacco products, exposure to FDA communication and tobacco marketing, risk perception related to a range of tobacco products, and tobacco use behavior. The application uses a mixture of measures that are standard, adapted and new measures to test hypotheses that use of any tobacco products remains high over time, that use of modified risk tobacco products increases in this population over time, that exposure to FDA communications and tobacco marketing are differentially associated with level of tobacco risk-perception, and that level of risk perception s differentially associated with efforts to reduce or quit tobacco use in this population. Because this population is where smokers are concentrated, it is also where information identified in FDA priorities is most needed, but least available. The short term goal of this research is to understand use of tobacco products, marketing, messaging, and perceptions associated with those products, and their relation to tobacco use behavior in addiction treatment populations. The long-term goal is to support regulatory activity to reduce tobacco use and tobacco risks in this vulnerable population.